Product Description
Overall, the global coronary stents market was valued at nearly $5.3 billion in 2025. This is expected to increase over the forecast period at a CAGR of 0.3% to reach nearly $5.4 billion.
The full report suite on the global market for coronary stents includes bare-metal stents (BMSs) and drug-eluting stents (DESs).
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Coronary Stent Market Trends

A notable trend in the coronary stent market is the renewed focus on bioresorbable scaffolds. Several companies have started reallocating portions of their R&D budgets to integrate these scaffolds into DES designs.
Global Coronary Stent Market Share Insights

- Boston Scientific was the leading company in the global coronary stent market in 2025. Its success is largely driven by a dominant position in the DES segment, where it holds the largest market share. The company’s portfolio includes the PREMIER™ and SYNERGY™ DES lines, as well as the REBEL™ BMS product line.
- Medtronic has maintained a strong presence in both the BMS and DES markets in 2025. The company has expanded its market share in interventional cardiology in recent years through strategic acquisitions and the use of aggressive product bundling strategies.
- Abbott has established a strong presence in the DES market with its XIENCE™ line. Introduced in 2008, the XIENCE™ DES quickly became the most widely used coronary stent in the U.S. market. The original XIENCE™ stent, a second-generation design, incorporated specific modifications to reduce the risk of thrombosis.
Global Coronary Stent Market Segmentation Summary
- Coronary Stent Market – Further Segmented Into:
- Device Type: Bare-Metal Stent, and Drug-Eluting Stent.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.